This federal contract award is for the delivery of M-M-R II (Measles-Mumps-Rubella) vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,024.76 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a Department of Defense (DoD) agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,958.67 and is a firm fixed-price delivery order that runs through June 21, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of M-M-R II vaccine vials to the government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $1,024.76. The contract has a completion date of July 5, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical that runs through December 31, 2025. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The $1,661.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 24, 2025 with an ultimate completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,038.31 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a firm fixed price of $2,175.98 and a completion date of June 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $4,408.42, was awarded on July 8, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a completion date of July 9, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The award has a firm fixed price of $3,156.27 and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to...
This federal contract award, valued at $5,787.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The contract is for the delivery of M-M-R II vaccine vials, a vaccine used to prevent measles, mumps, and rubella. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2024. No set-aside designation was used for this award. Amerisourcebergen...